by adminAdrianRamirez | Feb 7, 2017 | HempMeds Brasil, Press Releases
National Health Surveillance Agency ANVISA Authorizes Doctor’s Prescription for RSHO™ to Treat Patient Suffering from Effects of Alzheimer’s Disease SAN DIEGO, Feb. 7, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly...
by adminAdrianRamirez | Feb 3, 2017 | Axim Biotechnologies, Company News, Media Coverage, Scientific Research
[vc_row][vc_column][vc_column_text]CanChew® Plus and AXIM® Biotechnologies were part of a news segment this week on CBS New York regarding the company’s ongoing clinical trials for the use of its patented CanChew® Plus CBD gum for the treatment of irritable bowel...
by adminAdrianRamirez | Feb 2, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 2, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds Brasil™ has launched a new website featuring brand information, a navigable web...
by adminAdrianRamirez | Feb 1, 2017 | HempMeds Brasil, Press Releases
AN DIEGO, Feb. 1, 2017 — Medical Marijuana, Inc. (otc pink:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® Brasil has begun the process of importing its Real Scientific Hemp Oil™ (RSHO) Green...
by adminAdrianRamirez | Jan 31, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Jan. 31, 2017 — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, is proud to announce the progress made by subsidiary HempMeds® Mexico upon the one-year anniversary of the first-ever import...
